Rigel Pharmaceuticals
RIGL
#6552
Rank
โ‚ฌ0.77 B
Marketcap
41,88ย โ‚ฌ
Share price
0.38%
Change (1 day)
74.92%
Change (1 year)

Earnings for Rigel Pharmaceuticals (RIGL)

Earnings in 2026 (TTM): โ‚ฌ78.58 Million

According to Rigel Pharmaceuticals's latest financial reports the company's current earnings are โ‚ฌ0.27 Billion. In 2025 the company made an earning of โ‚ฌ0.11 Billion, an increase over its 2024 earnings that were of โ‚ฌ23.34 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Rigel Pharmaceuticals from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚ฌ78.58 M-31.5%
2025 โ‚ฌ0.11 B391.35%
2024 โ‚ฌ23.34 M-244.27%
2023 -โ‚ฌ16.19 Million-66.79%
2022 -โ‚ฌ48.74 Million340.73%
2021 -โ‚ฌ11.06 Million-56.15%
2020 -โ‚ฌ25.22 Million-57.34%
2019 -โ‚ฌ59.13 Million-7.66%
2018 -โ‚ฌ64.03 Million-9.47%
2017 -โ‚ฌ70.73 Million24.46%
2016 -โ‚ฌ56.83 Million23.63%
2015 -โ‚ฌ45.97 Million-43.29%
2014 -โ‚ฌ81.06 Million2.5%
2013 -โ‚ฌ79.09 Million
2010 โ‚ฌ33.62 M-133.97%
2009 -โ‚ฌ98.99 Million-18.49%
2008 -โ‚ฌ0.13 Billion71.91%
2007 -โ‚ฌ70.65 Million84.74%
2006 -โ‚ฌ38.24 Million-10.17%
2005 -โ‚ฌ42.57 Million-15.73%
2004 -โ‚ฌ50.52 Million39.29%
2003 -โ‚ฌ36.27 Million10.3%
2002 -โ‚ฌ32.89 Million48.3%
2001 -โ‚ฌ22.18 Million-2.13%
2000 -โ‚ฌ22.66 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
โ‚ฌ9.13 B 11,157.26%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ12.73 B 15,583.79%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sangamo Therapeutics
SGMO
-โ‚ฌ98 Million-220.73%๐Ÿ‡บ๐Ÿ‡ธ USA
ChemoCentryx
CCXI.defunct
-โ‚ฌ0.12 Billion-242.92%๐Ÿ‡บ๐Ÿ‡ธ USA